(Q38663177)

5 September 2017

0 references

Clinical impact of BRAF mutation on the diagnosis and prognosis of papillary thyroid carcinoma: a systematic review and meta-analysis (English)

1 reference

5 September 2017

papillary thyroid cancer

1 reference

Zhen Wang

1

1 reference

5 September 2017

Jun-Qiang Chen

series ordinal

2

1 reference

5 September 2017

Jin-Lu Liu

series ordinal

3

1 reference

5 September 2017

Xin-Gan Qin

series ordinal

4

1 reference

5 September 2017

9 December 2015

1 reference

European Journal of Clinical Investigation

5 September 2017

1 reference

5 September 2017

46

1 reference

5 September 2017

2

1 reference

5 September 2017

146-157

1 reference

Guidelines of the French society of endocrinology for the management of thyroid nodules.

5 September 2017

1 reference

Changing patterns in the incidence and survival of thyroid cancer with follicular phenotype--papillary, follicular, and anaplastic: a morphological and epidemiological study

21 January 2018

1 reference

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer

21 January 2018

1 reference

Fine-needle aspiration biopsy of thyroid nodules: experience in a cohort of 944 patients.

21 January 2018

1 reference

From nodule to differentiated thyroid carcinoma: contributions of molecular analysis in 2012.

21 January 2018

1 reference

BRAF mutation in thyroid cancer

21 January 2018

1 reference

Proper indication of BRAF(V600E) mutation testing in fine-needle aspirates of thyroid nodules.

21 January 2018

1 reference

BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies.

21 January 2018

1 reference

Application of BRAF, NRAS, KRAS mutations as markers for the detection of papillary thyroid cancer from FNAB specimens by pyrosequencing analysis

21 January 2018

1 reference

BRAF mutation analysis and sonography as adjuncts to fine-needle aspiration cytology of papillary thyroid carcinoma: their relationships and roles.

21 January 2018

1 reference

Combined analysis of galectin-3 and BRAFV600E improves the accuracy of fine-needle aspiration biopsy with cytological findings suspicious for papillary thyroid carcinoma

21 January 2018

1 reference

BRAF(V600E) mutation analysis of liquid-based preparation-processed fine needle aspiration sample improves the diagnostic rate of papillary thyroid carcinoma.

21 January 2018

1 reference

Management of low-risk differentiated thyroid cancer

21 January 2018

1 reference

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer

21 January 2018

1 reference

BRAF mutation in papillary thyroid carcinoma in a Japanese population: its lack of correlation with high-risk clinicopathological features and disease-free survival of patients

21 January 2018

1 reference

BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma.

21 January 2018

1 reference

BRAF V600E status adds incremental value to current risk classification systems in predicting papillary thyroid carcinoma recurrence.

21 January 2018

1 reference

BRAF V600E mutational status in pediatric thyroid cancer.

21 January 2018

1 reference

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies

21 January 2018

1 reference

REporting recommendations for tumor MARKer prognostic studies (REMARK).

21 January 2018

1 reference

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

21 January 2018

1 reference

Practical methods for incorporating summary time-to-event data into meta-analysis

21 January 2018

1 reference

Can ultrasound be as a surrogate marker for diagnosing a papillary thyroid cancer? Comparison with BRAF mutation analysis

21 January 2018

1 reference

Contribution of the BRAF mutation analysis in calcified thyroid nodules.

21 January 2018

1 reference

Detection of BRAF mutation on fine needle aspiration biopsy specimens: a new diagnostic tool for papillary thyroid cancer

21 January 2018

1 reference

Diagnostic value of BRAF(V600E) mutation analysis of thyroid nodules according to ultrasonographic features and the time of aspiration

21 January 2018

1 reference

Pyrosequencing analysis for detection of a BRAFV600E mutation in an FNAB specimen of thyroid nodules

21 January 2018

1 reference

Reduction of false-negative papillary thyroid carcinomas by the routine analysis of BRAF(T1799A) mutation on fine-needle aspiration biopsy specimens: a prospective study of 814 thyroid FNAB patients.

21 January 2018

1 reference

Role of ultrasonographic/clinical profile, cytology, and BRAF V600E mutation evaluation in thyroid nodule screening for malignancy: a prospective study.

21 January 2018

1 reference

The BRAF(V600E) mutation is associated with malignant ultrasonographic features in thyroid nodules.

21 January 2018

1 reference

BRAF analysis by fine needle aspiration biopsy of thyroid nodules improves preoperative identification of papillary thyroid carcinoma and represents a prognostic factor. A mono-institutional experience.

21 January 2018

1 reference

Role of BRAFV600E mutation analysis and second cytologic review of fine-needle aspiration for evaluating thyroid nodule

21 January 2018

1 reference

Surgical results of thyroid nodules according to a management guideline based on the BRAF(V600E) mutation status

21 January 2018

1 reference

A high percentage of BRAFV600E alleles in papillary thyroid carcinoma predicts a poorer outcome.

21 January 2018

1 reference

Association between expression of X-linked inhibitor of apoptosis protein and the clinical outcome in a BRAF V600E-prevalent papillary thyroid cancer population

21 January 2018

1 reference

BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer

21 January 2018

1 reference

BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study

21 January 2018

1 reference

BRAF(V600E) mutation is associated with an increased risk of nodal recurrence requiring reoperative surgery in patients with papillary thyroid cancer.

21 January 2018

1 reference

BRAFV600E mutation in fine-needle aspiration aspirates: Association with poorer prognostic factors in larger papillary thyroid carcinomas.

21 January 2018

1 reference

Impact of lymph node metastases identified on central neck dissection (CND) on the recurrence of papillary thyroid cancer: potential role of BRAFV600E mutation in defining CND.

21 January 2018

1 reference

Impact of pathognomonic genetic alterations on the prognosis of papillary thyroid carcinoma. ESES vienna presentation

21 January 2018

1 reference

The BRAF(V600E) mutation influences the short- and medium-term outcomes of classic papillary thyroid cancer, but is not an independent predictor of unfavorable outcome.

21 January 2018

1 reference

Analysis of differential BRAF(V600E) mutational status in high aggressive papillary thyroid microcarcinoma.

21 January 2018

1 reference

Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma.

21 January 2018

1 reference

Association of BRAFV600E mutation with poor clinical prognostic factors and US features in Korean patients with papillary thyroid microcarcinoma

21 January 2018

1 reference

Association of the T1799A BRAF mutation with tumor extrathyroidal invasion, higher peripheral platelet counts, and over-expression of platelet-derived growth factor-B in papillary thyroid cancer.

21 January 2018

1 reference

Both BRAF V600E mutation and older age (≥ 65 years) are associated with recurrent papillary thyroid cancer

21 January 2018

1 reference

BRAF (V600E) mutation analysis in papillary thyroid carcinomas by peptide nucleic acid clamp real-time PCR.

21 January 2018

1 reference

BRAF mutation in the elderly submitted to thyroidectomy

21 January 2018

1 reference

BRAF V600E mutation is associated with tumor aggressiveness in papillary thyroid cancer.

21 January 2018

1 reference

BRAF(V600E) mutation in Turkish patients with papillary thyroid cancer: strong correlation with indicators of tumor aggressiveness.

21 January 2018

1 reference

BRAFV600E mutation does not serve as a prognostic factor in Korean patients with papillary thyroid carcinoma.

21 January 2018

1 reference

BRAFV600E status and clinical characteristics in solitary and multiple papillary thyroid carcinoma: experience of 512 cases at a clinical center in China

21 January 2018

1 reference

Clinical implication of highly sensitive detection of the BRAF V600E mutation in fine-needle aspirations of thyroid nodules: a comparative analysis of three molecular assays in 4585 consecutive cases in a BRAF V600E mutation-prevalent area.

21 January 2018

1 reference

Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers

21 January 2018

1 reference

Clinical implication of the BRAFV600E mutation in papillary thyroid carcinoma

21 January 2018

1 reference

Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature.

21 January 2018

1 reference

Detection of BRAF V600E mutation with thyroid tissue using pyrosequencing: comparison with PNA-clamping and real-time PCR.

21 January 2018

1 reference

Does BRAF V600E mutation predict aggressive features in papillary thyroid cancer? Results from four endocrine surgery centers

21 January 2018

1 reference

High prevalence of BRAF mutation in a Brazilian cohort of patients with sporadic papillary thyroid carcinomas: correlation with more aggressive phenotype and decreased expression of iodide-metabolizing genes.

21 January 2018

1 reference

Lymphatic mapping establishes the role of BRAF gene mutation in papillary thyroid carcinoma.

21 January 2018

1 reference

Mutations of the BRAF gene in papillary thyroid carcinoma in a Korean population

21 January 2018

1 reference

No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan.

21 January 2018

1 reference

Overexpression of miR-221 is associated with aggressive clinicopathologic characteristics and the BRAF mutation in papillary thyroid carcinomas.

21 January 2018

1 reference

The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma.

21 January 2018

1 reference

The role of BRAF(V600E) mutation as poor prognostic factor for the outcome of patients with intrathyroid papillary thyroid carcinoma.

21 January 2018

1 reference

The role of BRAFV600E mutation and ultrasonography for the surgical management of a thyroid nodule suspicious for papillary thyroid carcinoma on cytology

21 January 2018

1 reference

Fine-needle aspiration may miss a third of all malignancy in palpable thyroid nodules: a comprehensive literature review.

21 January 2018

1 reference

Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors

21 January 2018

1 reference

Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy.

21 January 2018

1 reference

Inhibitory effects of the mitogen-activated protein kinase kinase inhibitor CI-1040 on the proliferation and tumor growth of thyroid cancer cells with BRAF or RAS mutations

21 January 2018

1 reference

BAY 43-9006 inhibition of oncogenic RET mutants

21 January 2018

1 reference

The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/ECI.12577

1 reference

5 September 2017

1 reference